Document is current

Article History

Received: 12 January 2026

Accepted: 24 March 2026

First Online: 27 March 2026

Declarations

:

: María Inmaculada Domínguez-Mozo: nothing to disclose.Stefano Ruberto: nothing to disclose.Carla Rodríguez-García: nothing to disclose.Luisa María Villar: has served at scientific advisory boards, participated in meetings sponsored by, received speaking honoraria or travel funding or research grants from Roche, Sanofi, Merck, Biogen, Bristol Myers, and Novartis.Lucienne Costa-Frossard: reports compensation for consulting services and speaker honoraria from Biogen, Bristol Myers Squibb, Janssen, Merck-Serono, Novartis, Sanofi, Roche, and Teva.Noelia Villarrubia: nothing to disclose.Yolanda Aladro: has received research grants, travel support and lecturing and consulting fees from: Teva, Biogen, Roche, Merck, Novartis, Almirall, Sanofi-Genzime, Janssen and Bristol Myers Squibb.Ignacio Casanova-Peño: has received payments for consulting services from Novartis and Merck, speaking honoraria from Merck, Novartis, Sanofi, and Neuraxpharm, support for attending meetings from Merck, and research grants from TEVA and Sanofi.María Luisa Martínez-Ginés: has received compensation for consulting services and speaking fees from Merck, Biogen, Novartis, Sanofi-Genzyme, Almirall, ROCHE, BMS, Juvisé and TEVA.Jose Manuel García-Domínguez: has received speaker honoraria, research grants or advisor invitations from Bristol-Myers-Squibb, Johnson and Johnson, Biogen, Sanofi, Almirall, Merck, Roche, Zenas Pharma and Novartis.Isabel Ortega Madueño: nothing to disclose.Andrea Alonso Garrido: nothing to disclose.Guadalupe Pérez de Villar: nothing to disclose.María Ángel García-Martínez: nothing to disclose.Rafael Arroyo: has been a speaker or has participated in the advisory board of Novartis, Teva, Roche, Bristol, Janssem, Biogen, Merck and Sanofi-Genzyme.Roberto Álvarez-Lafuente: has received support for attending meetings from Biogen, Merck, Novartis, Sanofi-Genzyme and Neuraxpharm.